» Articles » PMID: 39697097

Senolysis by GLS1 Inhibition Ameliorates Kidney Aging by Inducing Excessive MPTP Opening Through MFN1

Overview
Specialty Geriatrics
Date 2024 Dec 19
PMID 39697097
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular senescence is a pivotal contributor to aging and age-related diseases. The targeted elimination of senescent cells, known as senolysis, has emerged as a promising therapeutic strategy for mitigating these conditions. Glutaminase 1 (GLS1), a key enzyme in the glutaminolysis pathway, has been implicated in various cellular senescence processes. However, its specific role in senescent renal tubular epithelial cells (TECs) remains unclear. This study investigates the role and underlying mechanisms of GLS1 in senescent TECs. Using d-galactose (d-gal)-induced senescence of HK-2 cells, we found that GLS1 inhibition eliminated senescent TECs by promoting excessive mitochondrial permeability transition pore (mPTP) opening. Mechanistically, the excessive mPTP opening is associated with the upregulation of mitofusin 1 (MFN1). Inhibition of GLS1 in d-gal-treated HK-2 cells induced a shift in mitochondrial dynamics from fission to fusion, accompanied by a significant increase in MFN1 expression. Knocking down MFN1 reduced the mPTP opening and the expression of mPTP-related genes (PPIF, VDAC, and BAX) in cells co-treated with d-gal and the GLS1 inhibitor BPTES. Moreover, treatment of aged mice with BPTES specifically eliminated senescent TECs and ameliorated age-associated kidney disease. These findings reveal that GLS1 inhibition eliminate senescent TECs by promoting excessive mPTP opening, suggesting that targeting GLS1 may be a novel senolytic strategy for alleviating aging-related kidney diseases.

Citing Articles

Estimating hip impact velocity and acceleration from video-captured falls using a pose estimation algorithm.

Michaels R, Barreira T, Robinovitch S, Sosnoff J, Moon Y Sci Rep. 2025; 15(1):1558.

PMID: 39789212 PMC: 11717977. DOI: 10.1038/s41598-025-85934-y.

References
1.
Gorgoulis V, Adams P, Alimonti A, Bennett D, Bischof O, Bishop C . Cellular Senescence: Defining a Path Forward. Cell. 2019; 179(4):813-827. DOI: 10.1016/j.cell.2019.10.005. View

2.
Karch J, Molkentin J . Identifying the components of the elusive mitochondrial permeability transition pore. Proc Natl Acad Sci U S A. 2014; 111(29):10396-7. PMC: 4115577. DOI: 10.1073/pnas.1410104111. View

3.
Colville A, Liu J, Rodriguez-Mateo C, Thomas S, Ishak H, Zhou R . Death-seq identifies regulators of cell death and senolytic therapies. Cell Metab. 2023; 35(10):1814-1829.e6. PMC: 10597643. DOI: 10.1016/j.cmet.2023.08.008. View

4.
Childs B, Gluscevic M, Baker D, Laberge R, Marquess D, Dananberg J . Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov. 2017; 16(10):718-735. PMC: 5942225. DOI: 10.1038/nrd.2017.116. View

5.
Nyengaard J, Bendtsen T . Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec. 1992; 232(2):194-201. DOI: 10.1002/ar.1092320205. View